| Dr Zackary Nathan Hall, OD | |
|
1175 W Boise Ave, Boise, ID 83706-3503 | |
| (208) 384-9194 | |
| Not Available |
| Full Name | Dr Zackary Nathan Hall |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 23 Years |
| Location | 1175 W Boise Ave, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588759229 | NPI | - | NPPES |
| 806981700 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | ODP-1066 (Idaho) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye 2 Eye Pllc | 5294768776 | 3 |
News Archive
A new study published Aug. 4 in the New England Journal of Medicine indicates that among African American U.S. Army Soldiers, sickle cell trait is not associated with an increase in mortality, but is associated with a modest increase in the risk of exertional rhabdomyolysis.
In the first experiment of its kind, investigators at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR), based at Stanford University, have shown that single-walled carbon nanotubes (SWCNTs) wrapped in poly(ethylene glycol), or PEG, can successfully target tumors in living animals.
Researchers from Mount Sinai School of Medicine have discovered a protein signaling pathway that becomes hyperactivated in human sarcoma cells, suggesting that medications to inhibit this pathway may be effective in the treatment of human sarcomas. The research is published in the current issue of the journal Cancer Cell.
A two-prong approach combining ibrutinib and rituximab (Rituxin) to treat aggressive chronic lymphocytic leukemia (CLL) produced profound responses with minor side effects in a Phase 2 clinical trial at the University of Texas MD Anderson Cancer Center.
To help patients work with their physicians to better understand medical imaging, Toshiba America Medical Systems, Inc. has launched myimagingexam.com, an educational resource Web site for patients receiving diagnostic imaging exams. The new site provides educational tools for patients to download and use with their physician before undergoing a medical imaging exam to better understand the imaging process and manage their own health.
› Verified 4 days ago
| Provider Name | Eye 2 Eye Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1467674572 PECOS PAC ID: 5294768776 Enrollment ID: O20050915000024 |
News Archive
A new study published Aug. 4 in the New England Journal of Medicine indicates that among African American U.S. Army Soldiers, sickle cell trait is not associated with an increase in mortality, but is associated with a modest increase in the risk of exertional rhabdomyolysis.
In the first experiment of its kind, investigators at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR), based at Stanford University, have shown that single-walled carbon nanotubes (SWCNTs) wrapped in poly(ethylene glycol), or PEG, can successfully target tumors in living animals.
Researchers from Mount Sinai School of Medicine have discovered a protein signaling pathway that becomes hyperactivated in human sarcoma cells, suggesting that medications to inhibit this pathway may be effective in the treatment of human sarcomas. The research is published in the current issue of the journal Cancer Cell.
A two-prong approach combining ibrutinib and rituximab (Rituxin) to treat aggressive chronic lymphocytic leukemia (CLL) produced profound responses with minor side effects in a Phase 2 clinical trial at the University of Texas MD Anderson Cancer Center.
To help patients work with their physicians to better understand medical imaging, Toshiba America Medical Systems, Inc. has launched myimagingexam.com, an educational resource Web site for patients receiving diagnostic imaging exams. The new site provides educational tools for patients to download and use with their physician before undergoing a medical imaging exam to better understand the imaging process and manage their own health.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zackary Nathan Hall, OD 1175 W Boise Ave, Boise, ID 83706-3503 Ph: (208) 384-9194 | Dr Zackary Nathan Hall, OD 1175 W Boise Ave, Boise, ID 83706-3503 Ph: (208) 384-9194 |
News Archive
A new study published Aug. 4 in the New England Journal of Medicine indicates that among African American U.S. Army Soldiers, sickle cell trait is not associated with an increase in mortality, but is associated with a modest increase in the risk of exertional rhabdomyolysis.
In the first experiment of its kind, investigators at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR), based at Stanford University, have shown that single-walled carbon nanotubes (SWCNTs) wrapped in poly(ethylene glycol), or PEG, can successfully target tumors in living animals.
Researchers from Mount Sinai School of Medicine have discovered a protein signaling pathway that becomes hyperactivated in human sarcoma cells, suggesting that medications to inhibit this pathway may be effective in the treatment of human sarcomas. The research is published in the current issue of the journal Cancer Cell.
A two-prong approach combining ibrutinib and rituximab (Rituxin) to treat aggressive chronic lymphocytic leukemia (CLL) produced profound responses with minor side effects in a Phase 2 clinical trial at the University of Texas MD Anderson Cancer Center.
To help patients work with their physicians to better understand medical imaging, Toshiba America Medical Systems, Inc. has launched myimagingexam.com, an educational resource Web site for patients receiving diagnostic imaging exams. The new site provides educational tools for patients to download and use with their physician before undergoing a medical imaging exam to better understand the imaging process and manage their own health.
› Verified 4 days ago
Vision Quest Medical Center, Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5680 W Gage St, Boise, ID 83706 Phone: 208-377-3937 Fax: 208-377-9455 | |
Dr. Gregory N Bodily, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 610 Americana Blvd, Boise, ID 83702 Phone: 208-344-2020 Fax: 208-344-2371 | |
Brent Sexauer, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1175 W Boise Ave, Boise, ID 83706 Phone: 208-384-9194 | |
J. Randall Pitman & Associates, P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 2051 S Cole Rd, Boise, ID 83709 Phone: 208-672-1200 Fax: 208-321-8728 | |
Dr. James W Vail, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3417 N Cole Rd, Boise, ID 83704 Phone: 208-377-1102 Fax: 208-377-5853 | |
Dr. Lavar W Kofoed, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 291 N Milwaukee St, Boise, ID 83704 Phone: 208-378-7020 Fax: 208-378-9460 | |
Dr. Paul Christian Neville, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 305 E Jefferson St, Boise, ID 83712 Phone: 208-381-6910 |